Navivumab

Navivumab
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T77094-1mg 1 mg - - -

7 - 10 business days*

233.00€
TGM-T77094-10mg 10 mg - - -

7 - 10 business days*

934.00€
 
Description: Navivumab (CT-P23) is a monoclonal antibody targeting the hemagglutinin HA of the... more
Product information "Navivumab"
Description: Navivumab (CT-P23) is a monoclonal antibody targeting the hemagglutinin HA of the influenza A virus, effectively neutralizing strains H1, H2, H5, and H9 by binding to the HA2 stem fusion domain [1]. Target: Influenza Virus
Supplier: TargetMol
Supplier-Nr: T77094

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Navivumab"
Write a review
or to review a product.
Viewed